novavax covid - Search News

News

Moderna’s New COVID Vaccine Gets FDA Green Light

Medical Xpress · 1d

Moderna's new lower-dose COVID-19 vaccine approved by FDA

The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome coronavirus 2.

Rheumatology Advisor · 1d

FDA Approves Novavax’s COVID-19 Vaccine Nuvaxovid

The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years.

Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it

The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective - and more by some measures - than the original shot, the company said.

CNET on MSN5d

Will I Have to Pay for a COVID Vaccine and How Much Will It Cost?

Uncertainty now dominates the COVID vaccine outlook after official recommendations were stripped for a variety of groups.

FDA approves Moderna’s lower-dose COVID-19 vaccine for some

The FDA approved Moderna’s lower-dose COVID-19 vaccine, but only for individuals aged 65 years or older and people aged 12 to ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results